PHIO · Phio Pharmaceuticals Corp. · Documents
$0.89
+0.00 (+0.31%)
At close · Oct 21
Return incl. dividend (before tax)
Going-concern doubt
— cleared Aug 6, 2026
The latest filing states the doubt was alleviated.
“The Company has limited cash resources, has incurred recurring operating losses and negative cash flows from its operations since its inception and has not yet recognized any product revenues. These factors have previously raised doubt about the Company's ability to continue as a going concern.”View the 10-Q filed Aug 6, 2026
Market Cap
$10.36M
Shares
11.62M
Volume · Oct 21
100.31K
Avg daily vol (3M)
135.49K
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | AI summary | Filing Date | Period | Open |
|---|---|---|---|---|
| 8-K | — | 2025-02-20 | 2025-02-19 | |
| S-1 | — | 2025-01-21 | — | |
| 8-K | — | 2025-01-17 | 2025-01-16 | |
| 8-K | — | 2025-01-15 | 2025-01-14 | |
| 8-K | — | 2025-01-14 | 2025-01-13 | |
| 8-K | — | 2025-01-13 | — | |
| 8-K | — | 2024-12-26 | 2024-12-23 | |
| 8-K | — | 2024-12-20 | 2024-12-19 | |
| 8-K | — | 2024-12-19 | 2024-12-18 | |
| 8-K | — | 2024-11-14 | — | |
| 10-Q | — | 2024-11-14 | 2024-09-30 | |
| 8-K | — | 2024-11-07 | — | |
| 10-Q | — | 2024-08-14 | 2024-06-30 | |
| 8-K | — | 2024-08-14 | — | |
| 8-K | — | 2024-08-01 | 2024-07-15 | |
| S-1 | — | 2024-07-26 | — | |
| 8-K | — | 2024-07-24 | 2024-07-19 | |
| 8-K | — | 2024-07-12 | 2024-07-11 | |
| 8-K | — | 2024-07-05 | 2024-07-03 | |
| 8-K | — | 2024-07-02 | 2024-07-01 | |
| 8-K | — | 2024-06-21 | 2024-06-17 | |
| 8-K | — | 2024-05-28 | — | |
| S-3 | — | 2024-05-20 | — | |
| 8-K | — | 2024-05-17 | 2024-05-16 | |
| S-1 | — | 2024-05-17 | — | |
| 10-Q | — | 2024-05-09 | 2024-03-31 | |
| 8-K | — | 2024-05-09 | — | |
| ARS | — | 2024-05-08 | 2023-12-31 | |
| DEFA14A | — | 2024-05-08 | — | |
| DEF 14A | — | 2024-05-08 | 2024-06-17 | |
| PRE 14A | — | 2024-04-22 | 2024-06-17 | |
| 8-K | — | 2024-04-02 | — | |
| 10-K | — | 2024-04-01 | 2023-12-31 | |
| 8-K | — | 2024-01-26 | 2024-01-24 | |
| S-1 | — | 2023-12-19 | — | |
| 8-K | — | 2023-12-08 | 2023-12-06 | |
| 10-Q | — | 2023-11-09 | 2023-09-30 | |
| 8-K | — | 2023-11-09 | — | |
| 8-K | — | 2023-08-21 | — | |
| 10-Q | — | 2023-08-10 | 2023-06-30 | |
| 8-K | — | 2023-08-10 | — | |
| 8-K | — | 2023-07-26 | 2023-07-20 | |
| DEF 14A | — | 2023-06-09 | 2023-07-20 | |
| ARS | — | 2023-06-09 | 2022-12-31 | |
| DEFA14A | — | 2023-06-09 | — | |
| S-1 | — | 2023-06-08 | — | |
| 8-K | — | 2023-06-02 | 2023-05-31 | |
| 8-K | — | 2023-05-24 | — | |
| 8-K | — | 2023-05-16 | — | |
| 10-Q | — | 2023-05-11 | 2023-03-31 |
Showing 51–100 of 174 filings